Contact
Please use this form to send email to PR contact of this press release:
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
TO:
Please use this form to send email to PR contact of this press release:
TG Therapeutics Announces FDA Approval of BRIUMVI™ (ublituximab-xiiy)
TO: